Tag: Starting

“The Drop” is Starting March 7 for HypeHorizen

 HypeHorizen, the innovative fashion and esports organization, is gearing up for the launch of “The Drop,” an exciting event to celebrate the company’s 3rd birthday. The event features three exclusive collections that capture the passions of fashion and esports enthusiasts alike: The Classics, Gamer Typography Merch, and The Elements of Hype. HypeHorizen’s leaders, Pandatastic Man and SweetSprinks share their excitement ahead of the launch. Pandatastic Man, HR Manager of HypeHorizen, said, “As we approach our third year in business, we are thrilled to present ‘The Drop’ to our community. The three collections we have curated are unique and inspired by ... Read more

The new Porsche 911 GT3 RS is in the starting blocks

WEBWIRE – Tuesday, July 26, 2022 The Porsche 911 GT3 is getting a big brother: the 911 GT3 RS, the new top of the 911 line in terms of performance will celebrate its world premiere on 17 August. The development of the high-performance sports car was inspired by the successful 911 RSR and 911 GT3 R GT racing cars. “The new 911 GT3 RS is even more optimised for track use than its predecessors. The spontaneously responsive, high-revving four-litre, six-cylinder boxer engine with approximately 500 PS has proven ideal for use at trackdays and club sport ... Read more

Starting its Industrial Investment in Biotech Companies, China Medical System (0867.HK) has Accelerated its Flywheel of Innovation

China Medical System Holdings Limited (0867.HK) (“CMS” or the “Company”) has been active in the market this year. From the acquisition of Luqa to enter the medical aesthetic market early this year, the Company has attracted the attention of the market. Recently, it announced a series of agreements signed with Trinomab Biotech Co., Ltd. (“Trinomab”). CMS will make an equity investment in Trinomab, and establish a joint venture (“JV”) with Trinomab, contributed with cash and related products technologies by CMS and Trinomab respectively. The Joint Venture will entrust CMS with the clinical development and commercialization of all its products in ... Read more